Shalby Limited , a prominent multi-specialty hospital chain, has announced its financial results for the second quarter of fiscal year 2026, revealing a mixed performance with notable growth in revenue and profit despite facing operational challenges.

Financial Highlights

• Consolidated revenue reached INR 289.00 crores, up 5.5% year-on-year from INR 274.00 crores in Q2 FY25.
• Consolidated Profit After Tax (PAT) surged by 200% to INR 7.30 crores, compared to INR 2.40 crores in the same quarter last year.
• EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) improved to INR 46.10 crores, marking a 15.8% increase from INR 39.80 crores in Q2 FY25.
• EBITDA margin expanded to 15.9% from 14.5% in the corresponding quarter of the previous fiscal year.

Operational Performance

The company reported improvements in key operational metrics:

• Average Revenue Per Occupied Bed (ARPOB) increased by 5.2% to INR 40,794 from INR 38,779 in Q2 FY25.
• Average Length of Stay (ALOS) slightly increased to 3.74 days from 3.60 days in the same period last year.

However, the company faced some challenges:

• Occupancy rate stood at 48%, with the number of occupied beds decreasing by 2.5% to 673 from 690 in Q2 FY25.
• Patient footfall saw a decline due to heavy rainfall and seasonal factors affecting planned surgeries and walk-in patients.

Segment Performance

Shalby's revenue mix for Q2 FY26 showed a diversified portfolio:

The company reported that its orthopedics segment, which historically contributed a significant portion of revenue, now accounts for 34% of the total, down from about 40% in previous quarters.

Challenges and Strategic Initiatives

Shalby International Hospital in Gurgaon faced headwinds, reporting a 22.7% year-on-year revenue decline to INR 20.00 crores and an occupancy rate of 21%. To address these challenges, the management has outlined several strategic initiatives:

1. Rebranding from Shalby Sanar International to Shalby International Hospital.
2. Leadership restructuring to drive performance improvements.
3. Onboarding new clinical talent and renowned doctors.
4. Focusing on both international and domestic patient segments.

The management expects these measures to yield positive results within the next two quarters, with the goal of achieving positive EBITDA for Shalby International Hospital in the next fiscal year.

Future Outlook

Shalby Limited is implementing several growth initiatives:

• Increasing adoption of robotic surgeries in orthopedics across all group entities.
• Adding two more linear accelerator (LINAC) bunkers in Surat and Ahmedabad for cancer treatment.
• Planning to install a PET/CT scan machine at the Naroda facility in Ahmedabad.
• Expanding the company's robotic surgery capabilities, with plans to add robots for general surgery, oncology surgery, and neurosurgery.

The company's management expressed confidence that these strategic investments, combined with the addition of new doctors and specialties, will fuel growth beyond the anticipated improvements in occupancy rates.

As Shalby Limited navigates through its operational challenges and implements its growth strategies, investors and industry observers will be keenly watching the company's performance in the coming quarters to assess the effectiveness of these initiatives in driving sustainable growth and profitability.

Shalby Limited , a leading healthcare services provider, has announced its financial results for the second quarter of fiscal year 2026, along with key corporate actions including the appointment of a new Chief Financial Officer and a restructuring of its subsidiary operations.

Financial Performance

Shalby delivered robust quarterly results for Q2 FY26:

• Consolidated revenue from operations: ₹2.85 billion, up from ₹2.67 billion year-on-year, representing a 6.7% increase
• Consolidated net profit: ₹83.80 million, surging from ₹34.00 million in the same period last year, marking a 146% increase
• EBITDA: ₹416.00 million, with margin expansion to 14.58% from 12.2%, indicating improved operational efficiency and profitability

Segment-wise Performance

Appointment of New CFO

Shalby Limited has appointed Mr. Amit Kumar as its new Chief Financial Officer and Key Managerial Personnel, effective November 13, 2025. Mr. Kumar's profile includes:

• Chartered Accountant with a Master's degree in Financial Management
• Over 18 years of experience across EdTech, Mobility, and Telecom sectors
• Expertise in controllership, commercial finance, FP&A, taxation, and M&A integration

Subsidiary Restructuring

The company has announced a restructuring of its subsidiary operations:

1. Shalby Advanced Technologies, Inc. USA (SAT Inc.) has approved the sale of its entire shareholding in Shalby Advanced Technologies India Private Limited (SAT India) to Shalby Medtech Limited (SMTL), a wholly-owned subsidiary of Shalby Limited.
2. SAT Inc. has granted license and manufacturing rights to SAT India for licensed products in India and international markets.
3. SAT India will provide Product Design and Engineering services to SAT Inc.
4. SAT India has become a wholly-owned subsidiary of SMTL and a step-down subsidiary of Shalby Ltd.

This restructuring aims to align strategies on marketing and product development across the group's subsidiaries.

Outlook

The strategic moves, including the appointment of an experienced CFO and the restructuring of subsidiary operations, indicate Shalby Limited's focus on strengthening its financial management and optimizing its corporate structure. The company appears to be positioning itself for improved operational efficiency in both its healthcare services and manufacturing segments. The significant increase in net profit and margin expansion demonstrate the company's ability to enhance its financial performance and operational efficiency.